Home›Companies›Biotech & Pharma›Centaur Bio

Centaur Bio Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 10, 2024·Suggest an edit

About Centaur Bio

Centaur Bio is a private company based in Charlotte, North Carolina, incorporated in 2021 in Delaware. It has reported $1,500,000 raised in two offerings on Form D since April 2023. Its chief executive is Michael Roberts.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 5, 2024Jul 30, 2024amended Sep 10, 2024$1,000,000fully sold26$38,462Debt, OptionsRule 506(b)Form D/A ↗1 earlier filing
Apr 6, 2023Apr 27, 2023amended Sep 7, 2023$500,000fully sold5$100KDebt, OptionsRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$1,500,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Centaur Bio's Form D filed Sep 10, 2024.

Sources

  1. SECCentaur Bio Inc. Form D, filed Jul 30, 2024
  2. SECCentaur Bio Inc. Form D, filed Apr 27, 2023
  3. SECCentaur Bio Inc. filing history